Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Herxheim

5 clinical trials in Herxheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Herxheim at a glance
5
clinical trials
  • Recruiting now0
  • Research sites1
Type of trial
Recruitment status
Quick filters

5 trials in Herxheim

Open in trial search

Pneumococcal immunisation

Not yet recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Pfizer Inc.

Meningococcal immunisation

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:RNMB1
  • Sponsor:Sanofi Pasteur Inc.

Pneumococcal immunisation

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1
  • Sponsor:Sanofi Pasteur Inc.

Meningitis meningococcal

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN
  • Sponsor:GlaxoSmithKline Biologicals

Meningococcal infection

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Herxheim

What the registry says about research in the country

01 Meningococcal Disease Prevention

Clinical trials focusing on meningococcal vaccination in various age groups, from infants to adolescents. Research examines the effectiveness of new vaccine formulations against multiple meningococcal serogroups.

  • Pentavalent Vaccine Development
  • Conjugate Vaccine Studies
  • Multi-serogroup Protection

Investigating innovative immunization strategies for comprehensive protection against meningococcal infection.

02 Pediatric Immunology

Studies evaluating the immunogenicity and safety of vaccines in different age-specific cohorts, with particular attention to dosing schedules and immune response patterns.

  • Infant Vaccination Programs
  • Toddler Immune Response
  • Adolescent Vaccine Safety

Research aims to establish optimal vaccination timing and dosing for maximum protective effect.

03 Vaccine Safety Assessment

Comprehensive evaluation of vaccine tolerability across different age groups, focusing on both immediate and long-term safety profiles.

  • Safety Profile Analysis
  • Reactogenicity Studies
  • Long-term Monitoring

Detailed assessment of vaccine safety parameters and immune response measurements.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.